$493.35
Price
$175.2B
Market Cap
62.5
P/E Ratio
43.1
Forward P/E
$7.89
EPS (TTM)
—
Dividend Yield
$5.9B
Cash
—
Total Debt
355M
Shares Out
$425.00
$609.08
52-Week Range
Institutional Ownership of INTUITIVE SURGICAL INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Giverny Capital|Francois Rochon
|
405 | $229376 | $526.96 | +1.54% |
Trading Activity for INTUITIVE SURGICAL INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q4 | |||||
| BUY | NEW | 405 | $229376 | $551.30 | |
| 2025-Q3 | |||||
| SELL | EXIT | — | — | $477.00 | |
| 2024-Q4 | |||||
| BUY | NEW | 405 | $211394 | $526.96 | |
| 2024-Q3 | |||||
| SELL | EXIT | — | — | $471.21 | |
| 2024-Q2 | |||||
| SELL | -56.2% | 337.9K | $150M | $394.87 | |
| BUY | NEW | 500 | $222425 | $394.87 | |
| 2024-Q1 | |||||
| SELL | -17.1% | 771.8K | $308M | $383.77 | |
| 2023-Q4 | |||||
| BUY | +45.3% | 931.5K | $314M | $295.68 | |
| 2023-Q3 | |||||
| BUY | NEW | 641.0K | $187M | $306.62 | |
| 2022-Q4 | |||||
| SELL | EXIT | — | — | $260.35 | |
| 2022-Q3 | |||||
| SELL | -99.9% | 3.9K | $730000 | $211.40 | |
| 2022-Q2 | |||||
| SELL | -3.7% | 3.4M | $690M | $223.30 | |
| SELL | EXIT | — | — | $223.30 | |
| 2022-Q1 | |||||
| BUY | +4.8% | 3.6M | $1.1B | $286.87 | |
| 2021-Q4 | |||||
| BUY | +210.0% | 3.4M | $1.2B | $340.49 | |
| SELL | EXIT | — | — | $340.49 | |
| BUY | +200.0% | 747 | $268000 | $340.49 | |
| 2021-Q3 | |||||
| BUY | +0.8% | 1.1M | $1.1B | $338.00 | |
| BUY | NEW | 64.5K | $21M | $338.00 | |
| 2021-Q2 | |||||
| BUY | +5.1% | 1.1M | $1.0B | $279.19 | |
| BUY | NEW | 249 | $229000 | $279.19 | |
| 2021-Q1 | |||||
| BUY | +2.7% | 1.0M | $766M | $250.36 | |
| 2020-Q4 | |||||
| BUY | +2.5% | 1.0M | $826M | $246.06 | |
| 2020-Q3 | |||||
| BUY | NEW | 984.8K | $699M | $228.62 | |
| BUY | NEW | 135 | $96000 | $228.62 | |
| 2018-Q3 | |||||
| SELL | EXIT | — | — | $175.65 | |
| 2018-Q1 | |||||
| SELL | -57.5% | 3.4K | $1M | $140.59 | |
Insider Trading for INTUITIVE SURGICAL INC
6 Months Insider Sentiment
Buy $0
Sell $77.2M
0
Buys
28
Sells
-77.2M
Net
2
Grants
Largest
$15.8M
Guthart
$13.9M
Guthart
$13.4M
Rosa
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 15, 2025 | Mark Brosius | SVP & Chief Mfg and Supply Chain Officer | SELL | 464 | $548.49 | $254K |
| Dec 12, 2025 | Mark Brosius | SVP & Chief Mfg and Supply Cha | SELL | 4.5K | $547.36 | $2.5M |
| Dec 12, 2025 | Mark Brosius | SVP & Chief Mfg and Supply Cha | EXERCISE | 4.5K | $79.64 | $358K |
| Dec 12, 2025 | Mark Brosius | SVP & Chief Mfg and Supply Chain Officer | SELL | 312 | $547.36 | $171K |
| Dec 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | SELL | 104 | $559.90 | $58K |
| Dec 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | EXERCISE | 104 | $229.39 | $24K |
| Dec 01, 2025 | Gary S Guthart | Executive Chair of the Board o | EXERCISE | 25.5K | $139.52 | $3.6M |
| Dec 01, 2025 | Curet Myriam | EVP & Chief Medical Officer | EXERCISE | 125 | $208.90 | $26K |
| Dec 01, 2025 | Curet Myriam | EVP & Chief Medical Officer | SELL | 125 | $568.99 | $71K |
| Dec 01, 2025 | Gary S Guthart | Executive Chair of the Board o | SELL | 22.8K | $570.89 | $13.0M |
| Nov 12, 2025 | Henry L Charlton | EVP & Chief Commercial and Mkt | SELL | 2.9K | $580.00 | $1.7M |
| Nov 12, 2025 | Henry L Charlton | EVP & Chief Commercial and Mkt | SELL | 2.9K | $580.00 | $1.7M |
| Nov 12, 2025 | Henry L Charlton | EVP & Chief Commercial and Mkt | EXERCISE | 2.9K | $242.34 | $702K |
| Nov 12, 2025 | Henry L Charlton | EVP & Chief Commercial and Mkt | EXERCISE | 2.6K | $245.60 | $630K |
| Nov 12, 2025 | Henry L Charlton | EVP & Chief Commercial and Mkt | EXERCISE | 636 | $347.42 | $221K |
| Nov 12, 2025 | Henry L Charlton | EVP & Chief Commercial and Mkt | SELL | 2.6K | $580.00 | $1.5M |
| Nov 12, 2025 | Henry L Charlton | EVP & Chief Commercial and Mkt | SELL | 636 | $580.00 | $369K |
| Nov 12, 2025 | Henry L Charlton | EVP & Chief Commercial and Mkt | EXERCISE | 2.9K | $177.99 | $516K |
| Nov 12, 2025 | Keith R Leonard | Director | GRANT | 1.6K | — | — |
| Nov 12, 2025 | Henry L Charlton | EVP & Chief Commercial and Mkt | SELL | 4.7K | $580.00 | $2.7M |
| Nov 12, 2025 | Craig H Barratt | Director | SELL | 750 | $580.00 | $435K |
| Nov 12, 2025 | Craig H Barratt | Director | EXERCISE | 750 | $71.32 | $53K |
| Nov 10, 2025 | Brian Edward Miller | EVP & Chief Digital Officer | SELL | 1.3K | $575.00 | $746K |
| Nov 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | EXERCISE | 105 | $229.39 | $24K |
| Nov 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | SELL | 105 | $560.00 | $59K |
| Nov 10, 2025 | Brian Edward Miller | EVP & Chief Digital Officer | EXERCISE | 2.2K | $208.90 | $460K |
| Nov 10, 2025 | Brian Edward Miller | EVP & Chief Digital Officer | EXERCISE | 1.3K | $229.39 | $298K |
| Nov 10, 2025 | Brian Edward Miller | EVP & Chief Digital Officer | SELL | 2.2K | $575.00 | $1.3M |
| Nov 05, 2025 | Fredrik Widman | VP Corporate Controller | EXERCISE | 1.9K | $77.00 | $147K |
| Nov 05, 2025 | Fredrik Widman | VP Corporate Controller | SELL | 159 | $550.00 | $87K |
| Nov 05, 2025 | Fredrik Widman | VP Corporate Controller | SELL | 1.9K | $550.00 | $1.0M |
| Nov 05, 2025 | Fredrik Widman | VP Corporate Controller | EXERCISE | 159 | $59.46 | $9K |
| Nov 03, 2025 | David J. Rosa | Chief Executive Officer (CEO) | GRANT | 5.5K | — | — |
| Oct 29, 2025 | Curet Myriam | EVP & Chief Medical Officer | SELL | 125 | $543.00 | $68K |
| Oct 29, 2025 | Curet Myriam | EVP & Chief Medical Officer | EXERCISE | 125 | $208.90 | $26K |
| Oct 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | EXERCISE | 1.2K | $229.39 | $264K |
| Oct 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | SELL | 5.0K | $548.43 | $2.8M |
| Oct 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | SELL | 1.4K | $548.43 | $756K |
| Oct 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | SELL | 1.2K | $548.43 | $632K |
| Oct 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | EXERCISE | 5.0K | $242.34 | $1.2M |
| Oct 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | EXERCISE | 1.4K | $208.90 | $288K |
| Oct 24, 2025 | David J. Rosa | Chief Executive Officer (CEO) | SELL | 24.5K | $547.55 | $13.4M |
| Oct 24, 2025 | Gary S Guthart | Executive Chair of the Board o | SELL | 1.4K | $546.35 | $765K |
| Oct 24, 2025 | Gary S Guthart | Executive Chair of the Board o | EXERCISE | 36.0K | $109.49 | $3.9M |
| Oct 24, 2025 | Gary S Guthart | Executive Chair of the Board o | SELL | 28.8K | $547.56 | $15.8M |
| Oct 24, 2025 | Craig H Barratt | Director | EXERCISE | 2.2K | $71.32 | $156K |
| Oct 24, 2025 | David J. Rosa | Chief Executive Officer (CEO) | EXERCISE | 27.0K | $79.64 | $2.2M |
| Oct 24, 2025 | Craig H Barratt | Director | SELL | 2.2K | $548.01 | $1.2M |
| Oct 10, 2025 | Gary Loeb | EVP & Chief Legal and Complian | EXERCISE | 2.6K | — | — |
| Sep 04, 2025 | Amy L Ladd | Director | SELL | 335 | $440.69 | $148K |
| Sep 03, 2025 | Amy L Ladd | Director | SELL | 336 | $470.11 | $158K |
| Aug 29, 2025 | Gary S Guthart | Executive Chair of the Board o | EXERCISE | 36.0K | $79.64 | $2.9M |
| Aug 29, 2025 | Gary S Guthart | Executive Chair of the Board o | SELL | 29.4K | $472.49 | $13.9M |